Target intelligence / Profile preview

Family with sequence similarity 131 member B (FAM131B)

Target
FAM131B
Molecular classification
Other (family with sequence similarity)
01

Overview

Family with sequence similarity 131 member B (FAM131B) is an intracellular protein encoded by the FAM131B gene. It belongs to the FAM131 family and is primarily localized in the cytosol and nucleoplasm. The principal biological and clinical relevance of FAM131B lies in its participation as a fusion partner with BRAF (FAM131B-BRAF fusion), where it drives constitutive activation of the MAPK pathway, contributing to oncogenesis in pilocytic astrocytoma[1][3][4][5][6]. FAM131B is also associated with myotonia congenita, though its molecular function remains largely uncharacterized. There are no approved drugs targeting FAM131B directly, but its fusion gene is a relevant biomarker and therapeutic context in certain cancers.

Other names
FAM131Bprotein FAM131BKIAA0773FAM131BphFAM131BE5RI17E5RJ60
02

Mechanism of action

Null for FAM131B directly; for FAM131B-BRAF fusion, constitutive activation of the MAPK pathway (via MEK phosphorylation) underlies its oncogenic mechanism

03

Biological functions

Cell cycle regulation (based on association with cell-cycle dependent proteins/transcripts)Potential role in oncogenic MAPK signaling (specifically as a fusion partner)Localization to cytosol and nucleoplasm, suggesting intracellular roles
04

Disease associations

Cancer (specifically, gene fusion in pilocytic astrocytoma)Myotonia congenita (autosomal dominant and recessive forms)Infectious disease (pathway association)
05

Safety considerations

Null; no agent directly targeting FAM131B is currently cited. For BRAF fusions, resistance and therapy-associated toxicities apply
06

Interacting drugs

None specifically; however, targeted therapies (e.g., MEK inhibitors) may indirectly affect cells harboring FAM131B-BRAF fusion
07

Biomarkers

FAM131B-BRAF fusion serves as a biomarker for pilocytic astrocytoma and may guide patient selection for MAPK pathway inhibitors

Beyond the preview

Go deeper on Family with sequence similarity 131 member B (FAM131B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 131 member B (FAM131B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call